1. Optimum strategies for detection of coronary artery disease and risk assessment

   • Ami E. Iskandrian
   • Frans J. Th. Wackers

   Announcement Pages: A6 - A6

2. Validation of noninvasive studies for detecting coronary artery disease: Beauty versus blood flow

   • Robert F. Wilson

   OriginalPaper Pages: S1 - S9

3. Pharmacologic stress versus maximal-exercise stress for perfusion imaging: Which, when, and why?

   • Manuel D. Cerqueira

   OriginalPaper Pages: S10 - S14

4. Tracer selection with different stress modalities based on tracer kinetics

   • Gary V. Heller

   OriginalPaper Pages: S15 - S21

5. Comparison of pharmacologic stress agents

   • Jeffrey A. Leppo

   OriginalPaper Pages: S22 - S26

6. Pharmacology of coronary vasodilation: A brief review

   • Cesare Orlandi

   ReviewPaper Pages: S27 - S30

7. Are separate normal data files required for quantitative pharmacologic stress radionuclide myocardial perfusion imaging?

   • Frans J. Th. Wackers

   OriginalPaper Pages: S31 - S40

8. Risk assessment in patients with stable coronary artery disease: Incremental value of nuclear imaging

   • Daniel S. Berman
   • Rory Hachmovitch

   OriginalPaper Pages: S41 - S49

9. Risk assessment after myocardial infarction: Have the rules changed with thrombolytic therapy?

   • Mario S. Verani

   OriginalPaper Pages: S50 - S59

10. Absolute quantitation of myocardial blood flow: The technical and clinical prospects for single-photon emission computed tomography

    • Jamshid Maddahi
    • Johannes Czernin

    OriginalPaper Pages: S60 - S65

11. The role of stress echocardiography versus stress perfusion: A view from the other side

    • Farooq A. Chaudhry

    OriginalPaper Pages: S66 - S74